Smart Syringes Market Size To Reach $2.22 Billion By 2033

October 2025 | Report Format: Electronic (PDF)

Smart Syringes Market Growth & Trends

The global smart syringes market is expected to reach USD 2.22 billion in 2033, registering a CAGR of 8.7% from 2025 to 2033, according to a new report by Grand View Research, Inc. In 2015, Some key factors driving the market include the rise in the patient population, the increasing number of needle stick injuries, and the spread of diseases due to unhygienic injection practices.

The injection practices and healthcare delivery standards are not uniform across the globe. The use of disposable syringes has been strongly advocated by various healthcare organizations across different countries; however, adherence to the patient safety guidelines is not adequately implemented in the LMIC (Low and Middle Income Countries).

As per the WHO records, the re-usage of syringes has boosted the infection cases of Ebola, malaria, Marburg virus, HIV, hepatitis, and other diseases in LMIC; these countries have been suffering with a huge infectious diseases burden due to the high transmission rates of blood-borne virus infections. Increasing awareness regarding the usage of smart syringes with safety mechanisms amongst the patients and the healthcare providers is anticipated to fuel the expansion of the smart syringes market over the forecast period.

As per the data published by the U.S. Occupational Safety and Health Administration (OSHA), nearly 5.6 million workers in the healthcare sector are at a high risk of occupational exposure to blood-borne pathogens, mainly on account of needle stick injuries and other metal injuries. The data also indicates that on an average 1,000 injuries occur per day in the U.S. hospitals, which translates to 385,000 needle stick and other injuries per year.

Some previously reported outbreaks due to the re-use of syringes include the following:

In 2007, hepatitis C outbreak in Nevada, U.S.
In 2009, more than 400 people were infected with Hepatitis B in Gujarat, India
In 2014, a group of more than 200 people(children and adults) living near Battambang, Cambodia, tested positive for HIV

Hence, in order to improve the healthcare outcomes and reduce the burden of infections, the healthcare practitioners and hospitals are expected to adopt the usage of smart syringes,which would significantly boost the smart syringes market over the forecast period.

key Request a free sample copy or view report summary: Smart Syringes Market Report

Smart Syringes Market Report Highlights

The auto-disable syringes segment led the market with the largest revenue share of 52.92% in 2024. This growth can be attributed to their built-in safety mechanism that prevents reuse, significantly reducing the risk of needle-stick injuries and the transmission of blood-borne infections.
The direct tenders (government & NGOs) segment led the market with the largest revenue share of 51.60% in 2024. This growth can be attributed to hospitals, government health agencies, and large healthcare institutions.
The needle retractable technology segment led the market with the largest revenue share of 64.85% in 2024. This can be attributed to built-in safety mechanism that automatically retracts the needle after use, effectively preventing reuse and reducing the risk of needle-stick injuries.
North America smart syringes market dominated the global market with the largest revenue share of 41.46% in 2024. The growth is attributed to the increased focus on patient safety, rising prevalence of blood-borne infections, and the growing adoption of advanced healthcare technologies.

Smart Syringes Market Segmentation

Grand View Research has segmented the global smart syringes market report based on product, application, distribution channel, technology, and region:

Smart Syringes Product Outlook (Revenue, USD Million, 2021 - 2033)

Auto-Disable Syringes
Active Safety Syringes
Passive Safety Syringes

Smart Syringes Application Outlook (Revenue, USD Million, 2021 - 2033)

Drug Delivery
- Insulin
- Vaccines
- Hormonal Therapies
- Oncology Drugs
- Others
Blood Specimen Collection
Catheter Syringe Flushing
Other Specialized Injection